Monitoring of anticoagulant therapy in cancer patients with thrombosis and the usefulness of blood activation markers.

Amiral, Jean; Seghatchian, Jerard

Amiral, Jean; Seghatchian, Jerard.

Afiliação

Amiral J; SH-Consulting, Andrésy (France) and Scientific and Technical Advisor for Hyphen BioMed, Sysmex group, Neuville Sur Oise, France. Electronic address: jamiral@hyphen-biomed.com.
Seghatchian J; International Consultancy in Blood Components Quality/Safety Improvement, Audit/Inspection and DDR Strategies, London, UK. Electronic address: jseghatchian@btopenworld.com.

Transfus Apher Sci ; 56(3): 279-286, 2017 Jun.

Article em En | MEDLINE | ID: mdl-28552490

Assuntos

Anticoagulantes/uso terapêutico; Biomarcadores/sangue; Neoplasias/tratamento farmacológico; Trombose/tratamento farmacológico; Anticoagulantes/farmacologia; Humanos; Trombose/sangue

Palavras-chave

Anticoagulant therapy; Blood activation; Laboratory monitoring; Occult cancer; Pathological markers; Thrombosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombose / Biomarcadores / Anticoagulantes / Neoplasias Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Transfus Apher Sci Assunto da revista: HEMATOLOGIA Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google